Google
×
INVESTORS · Profile · Financials Filings · Corporate Presentation · NEWS & EVENTS · Press Releases · In The News · Events. Open Menu Close Menu. Scinai · ABOUT.
Dec 30, 2022 · www.biondvax.com. Contact Details. Investor Relations | +972 8 930 2529 | ir@biondvax.com. Forward-Looking Statements. This press release ...
Nov 30, 2022 · www.biondvax.com. Contact Details. Investor Relations | +972 8 930 2529 | ir@biondvax.com. Forward Looking Statements. This press release ...
Oct 11, 2022 · Investors interested in meeting with Mr. Phillipson are welcome to contact BiondVax's investor relations team whose contact details are below.
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
Apr 17, 2023 · JERUSALEM, April 17, 2023 (GLOBE NEWSWIRE) -- via InvestorWire -- BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a biotechnology company focused ...
BiondVax Pharmaceuticals (BVXV) will release its next earnings report on Nov 27, 2023. In the last quarter BiondVax Pharmaceuticals reported -$0.455 EPS in ...
Missing: relations | Show results with:relations
Dec 8, 2022 · report, investor relations services, investment software, financial database analysis, organization of non-deal road shows, and attendance fees.
... Investor Relations, will attend and present at the LD Micro Main Event XV, an investor conference taking place October 25 to 27, 2022 in Los A... Newsfile ...
Oct 11, 2022 · Investors interested in meeting with Mr. Phillipson are welcome to contact BiondVax's investor relations team whose contact details are below.